Compare MPV & QSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MPV | QSI |
|---|---|---|
| Founded | 1988 | 2013 |
| Country | United States | United States |
| Employees | N/A | 145 |
| Industry | Finance Companies | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 182.5M | 165.6M |
| IPO Year | N/A | N/A |
| Metric | MPV | QSI |
|---|---|---|
| Price | $16.37 | $0.81 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $1.00 |
| AVG Volume (30 Days) | 23.3K | ★ 2.5M |
| Earning Date | 01-01-0001 | 05-07-2026 |
| Dividend Yield | ★ 8.71% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 1.71 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $618.07 |
| P/E Ratio | $9.60 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $15.05 | $0.69 |
| 52 Week High | $21.00 | $3.10 |
| Indicator | MPV | QSI |
|---|---|---|
| Relative Strength Index (RSI) | 55.42 | 40.98 |
| Support Level | $15.91 | $0.69 |
| Resistance Level | $17.57 | $1.11 |
| Average True Range (ATR) | 0.37 | 0.04 |
| MACD | 0.11 | 0.00 |
| Stochastic Oscillator | 94.48 | 40.68 |
Barings Participation Investors is a diversified closed-ended management investment company. The Trust's investment objective is to maintain a portfolio of securities providing a current yield and an opportunity for capital gains. Its principal investments are privately placed, below-investment grade, long-term debt obligations including bank loans and mezzanine debt instruments. The company invests in various sectors such as aerospace and defense; automotive; building materials; consumer products and others.
Quantum-Si Inc is a life sciences company focused on proteomics research and analytical technologies. It develops single-molecule detection platforms designed to enable next-generation protein sequencing (NGPS) and large-scale protein analysis. Its technology supports massively parallel sequencing of proteins and can also be applied to the study of nucleic acids, providing tools for researchers and clinical applications in molecular analysis. The company's revenue is derived from sales of products and services.